Literature DB >> 12113983

Quantitation of the flavonoid wogonin and its major metabolite wogonin-7 beta-D-glucuronide in rat plasma by liquid chromatography-tandem mass spectrometry.

Xiaoyan Chen1, Hongyan Wang, Yue Du, Dafang Zhong.   

Abstract

This study described the application of liquid chromatography-tandem mass spectrometry for the quantitation of wogonin and its major metabolite in rat plasma. Only one conjugated metabolite with glucuronic acid was identified by chromatographic and electrospray multi-stage mass spectrometric assay. A derivatization reaction with 2-chlorethanol further demonstrated that the metabolite was wogonin-7 beta-D-glucuronide (W-7-G), not wogonin-5 beta-D-glucuronide. Other conjugated metabolites, e.g., sulfates and glucosides, were not detected. The plasma concentration of free wogonin was determined using atmospheric pressure chemical ionization source in the selected reaction monitoring mode. The method had a lower limit of quantitation of 0.25 ng/ml for wogonin, which offered increased sensitivity, selectivity and speed of analysis over an existing method. Incubation of the plasma samples with beta-glucuronidase allows the quantitation of W-7-G. This quantitation method was successfully applied to a preclinical pharmacokinetic study of wogonin and its major metabolite, W-7-G, after an oral administration of 5 mg/kg wogonin to rats. Copyright 2002 Elsevier Science BV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12113983     DOI: 10.1016/s1570-0232(02)00288-x

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of wogonin and oroxylin A by human liver and intestinal microsomes.

Authors:  Qiong Zhou; Zhijie Zheng; Bijun Xia; Lan Tang; Chang Lv; Wei Liu; Zhongqiu Liu; Ming Hu
Journal:  Pharm Res       Date:  2010-04-22       Impact factor: 4.200

2.  Mechanism in the existent difference in form of wogonin/wogonoside between plasma and intestine/liver in rats.

Authors:  Qian Wang; Rong Shi; Yan Dai; Yuanyuan Li; Tianming Wang; Yueming Ma; Nengneng Cheng
Journal:  RSC Adv       Date:  2018-01-16       Impact factor: 4.036

3.  Characterization and Bioavailability of Wogonin by Different Administration Routes in Beagles.

Authors:  Na Zhu; Jian-Chun Li; Jin-Xiu Zhu; Xiu Wang; Jin Zhang
Journal:  Med Sci Monit       Date:  2016-10-16

4.  Separation methods used for Scutellaria baicalensis active components.

Authors:  Hua-Bin Li; Yue Jiang; Feng Chen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-12-05       Impact factor: 3.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.